Latest filing published 02 Nov 2006 for ACHILLION PHARMACEUTICALS INC.
Insider track record
No signal scores available.
Schroder Venture Managers Ltd: trading record in brief
This profile gathers the share dealings of Schroder Venture Managers Ltd across 2 companies, led by Solexa, Inc. and Achillion Pharmaceuticals Inc. Over a trading history stretching from 17 January 2006 to 31 October 2006, the count stands at 7 filings.
On the market, this insider has only sold: 6 sales, €3.9M in total.
The latest filing, published on 2 November 2006, reports a transaction in Achillion Pharmaceuticals Inc. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. Section 16 rules allow two business days to file each Form 4. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Schroder Venture Managers Ltd
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 1,710,231 shares0Common StockSEC:0001181431-06-061381:0
- 243,901 shares@ US$11.34Common StockSEC:0001209191-06-004087:0
- 103,876 shares@ US$11.34Common StockSEC:0001209191-06-004087:1
- 27,683 shares@ US$11.34Common StockSEC:0001209191-06-004087:2
- 7,014 shares@ US$11.34Common StockSEC:0001209191-06-004087:3
- 30,041 shares@ US$11.34Common StockSEC:0001209191-06-004087:4
- 3,763 shares@ US$11.34Common StockSEC:0001209191-06-004087:5
7 of 7 declarations
